Works matching IS 00099236 AND DT 2011 AND VI 89 AND IP 2
Results: 33
Refining the Benefit-Risk Framework for the Assessment of Medicines: Valuing and Weighting Benefit and Risk Parameters.
- Published in:
- 2011
- By:
- Publication type:
- Proceeding
Regulatory Science: What It Is and Why We Need It.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 291, doi. 10.1038/clpt.2010.276
- By:
- Publication type:
- Article
State of the Controlled Clinical Trial Enterprise in the United States.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 225, doi. 10.1038/clpt.2010.292
- By:
- Publication type:
- Article
Changes to ICH Guideline M3: New and Revised Guidance on Nonclinical Safety Studies to Support Human Clinical Trials and Marketing Authorization.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 295, doi. 10.1038/clpt.2010.273
- By:
- Publication type:
- Article
What Constitutes an Optimal Portfolio of Pharmaceutical Compounds?
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 304, doi. 10.1038/clpt.2010.247
- By:
- Publication type:
- Article
Biclustering of Adverse Drug Events in the FDA's Spontaneous Reporting System.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 243, doi. 10.1038/clpt.2010.285
- By:
- Publication type:
- Article
Has the FDA Amendments Act of 2007 Impaired Drug Development?
- Published in:
- 2011
- By:
- Publication type:
- Opinion
The African Medicines Regulatory Harmonization Initiative: Rationale and Benefits.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 149, doi. 10.1038/clpt.2010.323
- Publication type:
- Article
CORRIGENDUM: Pharmacokinetics of an anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects.
- Published in:
- 2011
- Publication type:
- Correction Notice
Application of the BRAT Framework to Case Studies: Observations and Insights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 217, doi. 10.1038/clpt.2010.280
- By:
- Publication type:
- Article
Why, When, and How Should Pharmacogenetics Be Applied in Clinical Studies?: Current and Future Approaches to Study Designs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 198, doi. 10.1038/clpt.2010.274
- By:
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 160, doi. 10.1038/clpt.2010.325
- Publication type:
- Article
The Emergency Use Authorization of Peramivir IV: A View from the Manufacturer.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
A Randomized, Placebo-Controlled Trial of Sustained-Release Dextroamphetamine for Treatment of Methamphetamine Addiction.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 276, doi. 10.1038/clpt.2010.307
- By:
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 158, doi. 10.1038/clpt.2010.324
- Publication type:
- Article
Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000-2009.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 183, doi. 10.1038/clpt.2010.286
- By:
- Publication type:
- Article
Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory Review.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 259, doi. 10.1038/clpt.2010.298
- By:
- Publication type:
- Article
Quantification of Cerebral Blood Flow as Biomarker of Drug Effect: Arterial Spin Labeling phMRI After a Single Dose of Oral Citalopram.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 251, doi. 10.1038/clpt.2010.296
- By:
- Publication type:
- Article
Clinical Pharmacology for Development of Topical Dermatological Products: Present and Future Opportunities for Safety and Efficacy.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
ERRATUM: Dipeptidyl Peptidase-4 Inhibitors Administered in Combination With Metformin Result in an Additive Increase in the Plasma Concentration of Active GLP-1.
- Published in:
- 2011
- Publication type:
- Correction Notice
Portfolio Selection and Management in Pharmaceutical Research and Development: Issues and Challenges.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 300, doi. 10.1038/clpt.2010.289
- By:
- Publication type:
- Article
Population Pharmacokinetics of Sulfadoxine and Pyrimethamine in Malawian Children With Malaria.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 268, doi. 10.1038/clpt.2010.297
- By:
- Publication type:
- Article
Translational Pharmacokinetics and Pharmacodynamics of an FcRn-Variant Anti-CD4 Monoclonal Antibody From Preclinical Model to Phase I Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 283, doi. 10.1038/clpt.2010.311
- By:
- Publication type:
- Article
Rifampin's Acute Inhibitory and Chronic Inductive Drug Interactions: Experimental and Model-Based Approaches to Drug-Drug Interaction Trial Design.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 234, doi. 10.1038/clpt.2010.271
- By:
- Publication type:
- Article
Current Challenges With Supply-Chain Integrity and the Threat to the Quality of Marketed Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 316, doi. 10.1038/clpt.2010.288
- By:
- Publication type:
- Article
Development of a Framework for Enhancing the Transparency, Reproducibility and Communication of the Benefit-Risk Balance of Medicines.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 312, doi. 10.1038/clpt.2010.291
- By:
- Publication type:
- Article
Comparative Effectiveness: The Fourth Hurdle in Drug Development and a Role for Clinical Pharmacology.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
Differential Impacts of CYP2C19 Gene Polymorphisms on the Antiplatelet Effects of Clopidogrel and Ticlopidine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 229, doi. 10.1038/clpt.2010.268
- By:
- Publication type:
- Article
Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 210, doi. 10.1038/clpt.2010.255
- By:
- Publication type:
- Article
Merrill Jon Egorin, MD, 1948-2010.
- Published in:
- 2011
- By:
- Publication type:
- Obituary
A Venture Capital View of Challenges, Opportunities, and Innovation in Biomedical Research.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 174, doi. 10.1038/clpt.2010.284
- By:
- Publication type:
- Article
Histamine: New Thoughts About a Familiar Mediator.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 189, doi. 10.1038/clpt.2010.256
- By:
- Publication type:
- Article